Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest SeraCare Life Sciences Inc. Stories

2014-04-08 08:31:04

MILFORD, Mass., April 8, 2014 /PRNewswire/ -- SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the launch of its new ACCURUN(®) 611 product, a robust product that demonstrates consistent performance over time. This reference material is designed to support detection of the Factor V Leiden mutation and the Factor II gene variant, as well as...

2014-02-11 08:32:13

MILFORD, Mass., Feb. 11, 2014 /PRNewswire/ -- SeraCare Life Sciences, a provider of high quality biological materials and reagents that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today introduced Dr. Jack Wands as the founding member of the SeraCare Science Advisory Board. This group will bring together thought leaders in emerging technologies and applications such as NexGen sequencing, clinical oncology and autoimmune disease to...

2013-12-17 08:28:59

MILFORD, Mass., Dec. 17, 2013 /PRNewswire/ -- SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced a new CMV DNA AccuSpan(TM) Linearity Panel. This new offering is a nine member panel made from serial dilutions of a cultured virus with established reactivity for CMV DNA. (Photo: http://photos.prnewswire.com/prnh/20131217/NE33384) Cytomegalovirus...

2013-08-19 23:20:31

Expands Product Offering for Diagnostics Research Milford, Massachusetts (PRWEB) August 19, 2013 SeraCare Life Sciences, a leader in life science products for the diagnostic industry, has acquired Kirkegaard & Perry Laboratories (KPL). KPL is a leading provider of antibodies and related reagents for the diagnostic and life sciences markets. With the acquisition, SeraCare has expanded its portfolio of products designed to help diagnostic researchers develop innovative in vitro...

2013-08-08 23:04:34

SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, completed its implementation of SAP® enterprise resource planning (ERP) software. Milford, MA (PRWEB) August 08, 2013 SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, completed its implementation...

2013-05-15 23:20:25

New panels provide manufacturers with material from a variety of donor genotypes and recent collection periods. Milford, Massachusetts (PRWEB) May 15, 2013 SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, announced it has launched three new ACCUVERT seroconversion panels and one new ACCUSET performance panel. These product additions expand the company´s offerings...

2012-02-18 08:00:00

NEW YORK, Feb. 18, 2012 /PRNewswire/ -- Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of SeraCare Life Sciences, Inc. (NASDAQ: SRLS) (referred to as "SeraCare" or the "Company") to Linden Capital Partners ("Linden"), in a cash transaction. (Logo: http://photos.prnewswire.com/prnh/20120119/MM38805LOGO ) Under the terms of the agreement, holders of outstanding shares of common stock of SeraCare will...

2012-02-13 05:46:00

MILFORD, Mass., Feb. 13, 2012 /PRNewswire/ -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the...

2012-02-10 06:03:00

MILFORD, Mass., Feb. 10, 2012 /PRNewswire/ -- SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today reported financial results for its 2012 fiscal first quarter ended December 31, 2011. (Logo: http://photos.prnewswire.com/prnh/20110324/NE70714LOGO ) For the quarter ended December 31, 2011, SeraCare reported revenue of $11.4...

2012-02-09 07:03:00

MILFORD, Mass., Feb. 9, 2012 /PRNewswire/ -- SeraCare Life Sciences (Nasdaq: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, announced today that the Company launched five new infectious disease panels and added a product line extension to its ACCURUN controls portfolio in January. These latest offerings include a performance panel for Parvovirus B19, most...